Clinical Trial

A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

Name: A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma — clinical trial record (NCT06478264)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated June 27, 2024 (before its estimated July 13, 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the efficacy and safety of adebrelimab combined with chemoradiotherapy in the treatment of esophageal small cell carcinoma

Trial Details

NCT Number	NCT06478264
Lead Sponsor	Zhangzhou Municipal Hospital
Conditions	Esophageal Small Cell Carcinoma
Enrollment	40 participants
Start Date	2024-07-13
Primary Completion	2026-07-13 (estimated)
Study Completion	2027-07-13 (estimated)
Updated on ClinicalTrials.gov	2024-06-27